Medscape Medical News Headlines

Drugmaker Partners Launch Copycat for Arthritis Drug Humira

Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie’s blockbuster arthritis drug Humira. Reuters Health Information

Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie’s blockbuster arthritis drug Humira. Reuters Health Information

2 years 1 month ago

Rheumatology, News

PAHO/WHO | Pan American Health Organization

Lições da pandemia devem ser transformadas em ações para que o mundo esteja mais bem preparado para futuras emergências, destaca diretor da OPAS na abertura da 17ª Conferência Nacional de Saúde, no Brasil

Lessons from the pandemic must be transformed into actions to prepare for future health emergencies, highlights PAHO director at opening of 17th National Health Conference, in Brazil

Cristina Mitchell

3 Jul 2023

Lessons from the pandemic must be transformed into actions to prepare for future health emergencies, highlights PAHO director at opening of 17th National Health Conference, in Brazil

Cristina Mitchell

3 Jul 2023

2 years 1 month ago

Health | NOW Grenada

CARPHA observes a decade of Public Health Service

“Moving forward, CARPHA will continue to support its Member States to prevent disease, promote health and wellness through leadership, partnership and innovation in public health”

2 years 1 month ago

Health, PRESS RELEASE, caribbean community, caribbean public health agency, caricom, carpha, coronavirus, COVID-19, joy st john

Healio News

Epcoritamab induces response in relapsed/refractory follicular lymphoma

More than 80% of a cohort of adults with relapsed or refractory follicular lymphoma exhibited an overall response to subcutaneously administered epcoritamab-bysp, according to topline data from the agent’s manufacturer.Epcoritamab-bysp (Epkinly; Genmab, AbbVie) is an investigational IgG1-bispecific antibody designed to bind to CD3 on T cells and CD20 on B cells simultaneously, while inducing T-

cell-mediated killing of CD20-positive cells.The open-label, multicenter phase 1/2 EPCORE NHL-1 trial assessed the safety and preliminary efficacy of epcoritamab-bysp among patients with relapsed,

2 years 1 month ago

Health – Dominican Today

Clinic for North American veterans opens in Bávaro – Punta Cana

Bávaro, Punta Cana.- Retired veterans of the United States Armed Forces who visit the Bávaro-Punta Cana area have an outpatient clinic at their service.

With the objective of improving their health and well-being, and honoring their sacrifices, the Veterans Community Care Abroad clinic was inaugurated on Avenida España, Corner Plaza, Bávaro.

Bávaro, Punta Cana.- Retired veterans of the United States Armed Forces who visit the Bávaro-Punta Cana area have an outpatient clinic at their service.

With the objective of improving their health and well-being, and honoring their sacrifices, the Veterans Community Care Abroad clinic was inaugurated on Avenida España, Corner Plaza, Bávaro.

Alfredo Cordero, retired Army captain and clinic executive, explained that this center is at the service of veterans who served the US for more than 120 days and who reside in the Dominican Republic, however, they are ready to receive active or retired Dominican soldiers, as well as other members of the local community on specific days.

Medical services are free of charge, as they are managed through a program of the US Armed Forces.

The clinic is an outpatient clinic that goes from an initial intervention with a general practitioner who deduces what conditions veterans suffer from, which have been produced or aggravated during military service.

General medicine, psychology, and rehabilitation of physical therapies are offered, as well as therapeutic and relaxing massages, psychiatry, and orthopedics, among other services.

Opening hours are Monday through Friday from 9:00 a.m. to 5:00 p.m. to 5:00 p.m. and Saturdays from 9:00 a.m. to 1:00 p.m.
Phone: (809) 795-1198
WA: (809) 841-1198
Website: www.vccavet.com

 

2 years 1 month ago

Bavaro & Punta Cana, Health, Local, tourism

Jamaica Observer

'Game changer'

PARTNERS Interventional Centre of Jamaica (PICJ) has introduced a groundbreaking medical procedure that will revolutionise the treatment of aortic valve stenosis — a condition where the aortic valve in the heart becomes narrowed — in Jamaica.

The procedure, done for the first time in Jamaica on June 16, 2023 at PICJ, is called transcatheter aortic valve replacement/implantation (TAVR/I).

The procedure was led by Miami-based Jamaican interventional and structural cardiologist Dr Shaun Smithson, with cardiothoracic surgeon Dr Roger Irvine as backup.

The TAVR is a minimally invasive procedure where the aortic heart valve is replaced, not by the conventional open-chest technique on a non-beating heart but introduced from a blood vessel in the groin via a long catheter, put in position and attached while the heart is still beating.

It is done using X-ray guidance, and except for the puncture wound in the groin for the introduction of the catheter necessary for the procedure, there are no other cuts on the skin.

It can be done with only sedation, versus a surgical aortic valve replacement which requires general anaesthesia. It is a procedure indicated best for a narrowed aortic valve (stenotic) in someone thought too frail to safely undergo surgical aortic valve replacement. Most patients go home in one to two days following the procedure.

In this case, the patient was an older gentleman with multiple risk factors for a poor outcome with the conventional surgical valve replacement. The TAVR allowed the patient to have a short length of stay at the hospital and a quicker return to his normal daily activities.

"TAVR is a minimally invasive procedure and is generally preferred for higher-risk or elderly patients, while SAVR (surgical aortic valve replacement) is considered for younger and lower-risk patients. SAVR is an open-heart surgery operation where the diseased valve is replaced with a prosthetic valve. This has a higher risk of periprocedural complications, including stroke, and longer length of stay in hospital for recovery," Dr Smithson told the Jamaica Observer.

Further, Dr Smithson said the procedure is "a complete game-changer not only for Jamaica but the Caribbean".

"Patients will now have the option of a minimally invasive procedure that is commonly offered in more developed countries. The procedure utilises significantly less hospital resources compared to SAVR, making it more easily accessible to more patients that need to be treated," he said.

Following the procedure, the patient was awake and arousable from anaesthesia in less than an hour after completion, and was in great spirits as he felt immediate improvement.

The TAVR improves the patient's lifestyle by relieving symptoms associated with aortic valve stenosis.

"These include shortness of breath, fatigue, and chest pain. By restoring proper blood flow TAVR enhances physical capacity and enables individuals to engage in activities they previously found challenging. The minimally invasive nature of TAVR also leads to faster recovery times, allowing for a quicker return to normal daily activities," Dr Smithson said.

In reference to the efficacy of the procedure, Dr Smithson added, "Prior to the commencement of the procedure I hosted a valve conference outlining the patient's risk factors and clinical data consistent with severe aortic stenosis. During this presentation we also discussed the case plan which involves the sizing of the new valve, approach to valve implantation, and any significant areas of potential complications. Given the complexity of procedure we also ensure each member of the team is familiar and comfortable with their role and responsibilities.

"During my training at Houston Methodist Debakey Heart & Vascular Institute, one of the most renowned cardiac facilities in the world, I was privileged to be a part of some of the pivotal trials for the approval of this device. This experience has since allowed me to successfully initiate three valve programmes at hospitals in South Florida. The procedure went smoothly because of my familiarity with TAVR, in addition to comprehensive planning and adequate preparation."

Moreover, Dr Smithson said it was a privilege for him to come back to his home country and share his expertise in this regard.

"It was a pleasure to work alongside colleagues in the local medical community and forge new relationships with international industry representatives in cardiology. I hope to continue to advance cardiac care in Jamaica and the Caribbean," he said.

In the meantime Dr Victor Elliot, interventional cardiologist and managing director at PICJ, said, "Being able to provide this level of cardiac care has always been our goal. To see a patient do a heart valve replacement without the need for days in ICU post-recovery, awake responsive, is truly remarkable. For us, this is just the beginning."

2 years 1 month ago

Jamaica Observer

New report calls for greater attention to children’s vital first years

A new progress report launched by the World Health Organization (WHO) and UNICEF highlights the need to step up investment in nurturing care — especially in the poorest and most fragile countries — with the first years of a child's life providing irreplicable opportunities to improve lifelong health, nutrition and well-being.

The report tracks progress against the global nurturing care framework, a seminal guidance document for supporting the healthy physical, intellectual, and emotional development of young children. This framework promotes an integrated approach to early childhood development, covering nutrition, health, safety and security, early learning, and responsive caregiving as essential areas for interventions.

"Early childhood development provides a critical window to improve health and well-being across life — with impacts that resonate even into the next generation," said Dr Anshu Banerjee, director of maternal, newborn, child and adolescent health and ageing at WHO. "While this report shows encouraging progress, greater investment is needed in these foundational early years so that children everywhere have the best possible start for a healthy life ahead."

A child's early experiences have a profound impact on their overall health and development. They affect health, growth, learning, behaviour and — ultimately — adult social relationships, well-being and earnings. The period from pregnancy to the age of three is when the brain develops fastest, with over 80 per cent of neural development happening during this time.

"Every child has the right to the best start in life," said Dr Victor Aguayo, director of nutrition and child development at UNICEF. "This includes the right to good nutrition and stimulation, responsive care and early learning, health and a safe environment. These rights provide children with the opportunity to grow and develop to their full potential. As children thrive, entire communities grow, and a sustainable future is possible."

According to the report, political commitment to early childhood development has increased since the framework was launched five years ago. Close to 50 per cent more countries have developed related policies or plans, and services have expanded. In a recent rapid survey, more than 80 per cent of responding countries reported training frontline workers to support families in providing early learning activities and responsive caregiving.

At the same time, increased investments are needed to scale up services and demonstrate impact, especially amongst vulnerable populations. Ensuring adequate support for children with developmental difficulties and addressing caregiver psychosocial well-being are part of this agenda.

"To improve the health of children, we must not only focus on meeting their immediate physical needs, but also ensure they are able to learn effectively, and develop positive, emotionally rewarding relations with people around them," said Dr Bernadette Daelmans, head of child health and development at WHO. "This is the role of nurturing care — laying the foundations for healthy brain development with lifelong implications for learning, health and well-being."

Efforts to create enabling environments for early childhood development require cohesive efforts — with dedicated financing — across a range of different sectors, the report notes, including health, education, sanitation, and protection services. Family-friendly policies supporting equitable access to affordable, high-quality childcare are also important.

Moving forward, the report highlights the significance of two new measures for improving data on progress — the early childhood development index 2030 and the global scales for early development — which can now be used to assess early childhood development starting soon after birth.

The Nurturing Care Framework was launched in 2018 by WHO, UNICEF and the World Bank Group, in collaboration with the Partnership for Maternal, Newborn and Child Health (PMNCH) and the Early Childhood Development Action Network. Its five strategic actions are: i) lead and invest; ii) focus on families and their communities; iii) strengthen services; iv) monitor progress; and v) scale up and innovate. It is complemented by a handbook, practice guide, thematic briefs, country profiles and an active website to help practitioners and policymakers support nurturing care and improve early childhood development at scale.

For more information see https://nurturing-care.org.

2 years 1 month ago

Jamaica Observer

The evolution of artificial intelligence in medicine

ARTIFICIAL intelligence (AI) has emerged as a transformative force in various industries, and its impact on the field of medicine is particularly remarkable.

With advancements in machine learning, deep learning, and data analytics, AI has revolutionised health care by enhancing diagnosis, improving treatment outcomes, and facilitating efficient health-care delivery. In our column today we will explore the profound influence of AI in medicine, highlighting its potential, challenges, and prospects.

Early detection and diagnosis: AI algorithms have demonstrated exceptional capabilities in early detection and accurate diagnosis of various medical conditions. Machine learning models trained on vast amounts of medical data can analyse symptoms, medical history, and imaging scans with remarkable accuracy. This assists health-care professionals in identifying diseases at earlier stages, leading to timely interventions and improved patient outcomes. For example, AI-based systems have been developed to detect cancerous cells in mammograms and identify abnormalities in retinal scans, aiding in the early detection of breast cancer and diabetic retinopathy.

Personalised treatment: Another significant area wherein AI has made remarkable progress is personalised treatment. By leveraging patient-specific data — including genetic information, medical records, and treatment outcomes — AI algorithms can provide tailored treatment recommendations. This allows physicians to optimise therapies, predict drug responses, and minimise adverse effects. Additionally, AI-powered tools can assist in precision surgery by providing real time guidance and enhancing surgical accuracy, leading to better patient safety and improved surgical outcomes.

Health-care efficiency: AI technologies have the potential to streamline health-care operations, reducing costs and enhancing efficiency. Natural language processing (NLP) algorithms can analyse vast amounts of unstructured health-care data, such as clinical notes and research papers, to extract relevant information and generate insights. This aids in clinical decision-making, research, and drug discovery processes. Furthermore, AI-powered chat bots and virtual assistants can offer immediate responses to patient queries, schedule appointments, and provide basic medical advice, thus reducing the burden on health-care staff and enhancing patient satisfaction.

Predictive analytics and preventive medicine: AI's ability to analyse large datasets and identify patterns enables predictive analytics in medicine. By analysing patient data and identifying risk factors, AI algorithms can predict the likelihood of disease development or complications. This knowledge allows health-care providers to intervene early and implement preventive measures, reducing the overall burden on the health-care system. For example, AI models can predict the probability of readmission in patients with chronic conditions, enabling targeted interventions and reducing health-care costs. Recently, our colleagues at Yale University have shown that with AI analytics a large database of electrocardiograms can be used to predict patients with low-ejection fraction, which ordinarily would require echocardiogram study. Accurate prediction of low-ejection fraction with a low-cost, easy to perform technique like an electrocardiogram could be a potential game changer for low-resource economies like Jamaica.

Challenges and ethical considerations: While AI holds tremendous promise in medicine, several challenges must be addressed. First, the ethical implications of using AI in health care — such as data privacy, transparency, and bias — need careful consideration. Ensuring that AI algorithms are fair, inclusive, unbiased, and transparent is crucial for patient trust and equitable health-care delivery. Additionally, concerns regarding the potential displacement of health-care professionals and the need for continuous training and upskilling should be addressed.

Future prospects: The future of AI in medicine appears promising. Integration of AI with emerging technologies like the Internet of Medical Things (IoMT) and wearable devices will enable continuous remote monitoring, early detection of health issues, and proactive interventions. Additionally, AI can facilitate the development of personalised medicine by analysing genetic data and tailoring treatments based on individual variations. Furthermore, collaborations between medical professionals, researchers, and AI experts are essential to harness the full potential of AI in medicine. Our team at HIC is currently working with Yale University and Ultrasight, a leading AI pioneer from Israel, to use AI to deliver echocardiograms to rural communities and thus greatly expand access to cardiovascular care without the limitation of trained personnel and geography.

Artificial intelligence has brought transformative changes to the field of medicine, revolutionising diagnostics, treatment, and health-care delivery. The ability of AI to process vast amounts of data, identify patterns, and generate actionable insights has the potential to revolutionise healthcare systems worldwide. However, it is crucial to address the challenges associated with AI implementation and ensure ethical considerations are at the forefront. By embracing AI responsibly the medical community can leverage the immense potential of big data analytics to improve health-care delivery and efficiency.

In future columns we will address specific roles of AI in particular fields of medicine like cardiology, cancer care and women's health.

Dr Ernest Madu, MD, FACC and Dr Paul Edwards, MD, FACC are consultant cardiologists for the Heart Institute of the Caribbean (HIC) and HIC Heart Hospital. HIC is the regional centre of excellence for cardiovascular care in the English-speaking Caribbean and has pioneered a transformation in the way cardiovascular care is delivered in the region. HIC Heart Hospital is registered by the Ministry of Health and Wellness and is the only heart hospital in Jamaica. Send correspondence to info@caribbeanheart.com or call
876-906-2107.

2 years 1 month ago

Jamaica Observer

Improving access to water, sanitation and hygiene can save 1.4 million lives per year — WHO

HALF of the world's population still does not have adequate access to safe drinking water, sanitation and hygiene (WASH) which could have prevented at least 1.4 million deaths and 74 million disability-adjusted life years (DALYs) in 2019, according to the latest report by the World Health Organization (WHO) and an accompanying article published in

The Lancet
.

"With growing WASH-related health risks seen already today through conflicts, the emergence of anti-microbial resistance, the re-emergence of cholera hot spots, and the long-term threats from climate change, the imperative to invest is stronger than ever," said Dr Maria Neira, director, WHO Department of Environment, Climate Change and Health. "We have seen improvements in WASH service levels over the last 10 years, but progress is uneven and insufficient."

Burden of disease attributable to unsafe drinking water, sanitation, and hygiene: 2019 update presents estimates of the burden of disease attributable to unsafe drinking water, sanitation and hygiene for 183 WHO member states disaggregated by region, age and sex for the year 2019. The estimates are based on four health outcomes — diarrhoea, acute respiratory infections, under-nutrition, and soil-transmitted helminthiases.

Diarrhoeal disease accounted for most of the attributable burden, with over one million deaths and 55 million DALYs. The second-largest contributor was acute respiratory infections from inadequate hand hygiene, which was linked to 356,000 deaths and 17 million DALYs.

DALYs represents the loss of the equivalent of one year of full health. In relation to a disease or condition DALYs are the sum of years of life lost due to premature mortality and the years lived with a disability due to prevalent cases of the disease or health condition in a population.

Among children under five, unsafe WASH was responsible for 395,000 deaths and 37 million DALYs, representing 7.6 per cent of all deaths and 7.5 per cent of all DALYs in this age group. This included 273,000 deaths from diarrhoea and 112,000 deaths from acute respiratory infections. These diseases are the top two infectious causes of death for children under five globally.

Important disparities were noted between regions and income groups. More than three-quarters of all WASH-attributable deaths occurred in the WHO African and South-East Asia regions, while 89 per cent of attributable deaths were from low- and lower-middle income countries. However, even high-income countries are at risk, as 18 per cent of their diarrhoeal disease burden could be prevented through improved hand hygiene practices.

While these estimates included four health outcomes for which data were available to quantify the impact, the true burden is likely to be much higher. The impacts of unsafe WASH on health are wide-ranging and go beyond disease by affecting social and mental well-being. In addition, climate change is likely to exacerbate many WASH-related diseases and risks which are not fully captured in the present estimates.

To reduce the WASH-attributable burden of disease, WHO urges governments to take the following actions with support from UN agencies, multilateral partners, the private sector and civil society organisations:

Radically accelerate action to make safe WASH a reality for all. The mid-term comprehensive review of the International Decade for Action Towards the Sustainable Development Goals (SDG) saw renewed commitments from governments to accelerate progress towards the goal of universal access to safe WASH. By quantifying for the first time the health gains associated with higher WASH service levels, the updated estimates provide strong evidence to support efforts to take these commitments to action.

Focus efforts on the poorest and most disadvantaged. The burden of disease is largely driven by inadequate access in low- and middle-income countries, and national estimates on WASH access often hide disparities within countries. Access to WASH services is typically lower among rural populations and lower socio-economic groups. Even in high-income countries, where access to safely managed drinking water and sanitation services is generally high, certain marginalised communities are underserved and face higher risks.

Adapt national monitoring systems to improve data on population exposure to safely managed services. Data on higher levels of WASH services remain sparse in many countries. Governments should adapt national and local monitoring systems taking into consideration the higher service levels called for in the SDG framework, enabling a more accurate reflection of the full burden of disease associated with unsafe WASH.

2 years 1 month ago

Health – Demerara Waves Online News- Guyana

Prosecutors Code dictates Dharamlall should be charged based on “Public interest”- GHRA

-Code also considers health of victim, withdrawal from case Guyana’s Code for Prosecutors provides sufficient basis for Local Government Minister Nigel Dharamlall  to be charged with the rape of a 16-year old girl although the complainant has formally asked to withdraw the complaint, the Guyana Human Rights Association (GHRA) said on Saturday. “Public interest considerations ...

-Code also considers health of victim, withdrawal from case Guyana’s Code for Prosecutors provides sufficient basis for Local Government Minister Nigel Dharamlall  to be charged with the rape of a 16-year old girl although the complainant has formally asked to withdraw the complaint, the Guyana Human Rights Association (GHRA) said on Saturday. “Public interest considerations ...

2 years 1 month ago

Courts, Crime, Health, legal, News

Health – Dominican Today

Cardiology Institute provides new cardiologists

Ten new specialists in cardiology, two in echocardiography, and an intensivist were presented to the country yesterday by the Dominican Institute of Cardiology Association (AIDC) to increase the health system’s response to the increase in cardiovascular diseases.

The new specialists were presented during yesterday’s celebration of the forty-eighth promotion of Cardiologists, the twenty-sixth graduation of Cardiologists-Ecocardiographers, and the second promotion of Intensivist Cardiologists.

With this promotion, the Institute of Cardiology joins the delivery of new specialists in the different medical branches that have made this week other teaching hospitals in the country, among them the Salvador B. Gautier and José María Cabral y Báez, which are developing various training programs. The event was headed by the medical director of the Institute of Cardiology, Dr. Mayra Melo, and the deputy director, Dr. Josué Pichardo, among other authorities.

When delivering the central words, Melo exhorted the new cardiologists to practice medicine with the human quality that the health center preaches and that is always focused on the benefit of the patients, “especially at this time when the aftermath of the health crisis that we recently experienced with Covid-19 is severely affecting them”.

“Today we have the satisfaction of duty fulfilled, as we are adding to the Dominican health system, ten specialists in the field of cardiology, two in echocardiography and an intensivist, who have successfully completed the program established by the direction of medical residencies of the Ministry of Public Health, the Ministry of Higher Education, Science and Technology, endorsed by the Autonomous University of Santo Domingo,” he said. They were sworn in by Dr. Aimée Flores, Teaching Coordinator of the AIDC, and Dr. Natividad Díaz, head of the Teaching Department of the AIDC, presented them with the certification.

2 years 1 month ago

Health, Local

Health – Dominican Today

Fundraising for Cystic Fibrosis Patients

The Dominican Cystic Fibrosis Foundation (Fundofq) will hold a fundraising event to acquire medicines for children suffering from Cystic Fibrosis nationwide.

Under the name “Parade of Generations,” this event will take place this Sunday, July 2, at 4:00 in the afternoon within the framework of the VEST International, an outstanding exhibition on beauty, health, energy, and wellness, which will take place from June 30 to July 2 this year at the Catalonia Hotel & Resort, in Santo Domingo.

With the purchase of a 2,000 pesos ticket, attendees will be able to enjoy the parade, featuring the participation of families with children affected by Cystic Fibrosis. This will be an opportunity to raise awareness in the community about this disease and raise the necessary funds to improve the patient’s quality of life. Alexandra Tabar, president of the foundation, emphasized that they need resources to support their beneficiaries.

2 years 1 month ago

Health, Local

Health | NOW Grenada

16 students in National Diabetes Quiz final

The competition will take place at the Grenada Youth Centre on Wednesday, 5 July 2023, from 9 am

View the full post 16 students in National Diabetes Quiz final on NOW Grenada.

The competition will take place at the Grenada Youth Centre on Wednesday, 5 July 2023, from 9 am

View the full post 16 students in National Diabetes Quiz final on NOW Grenada.

2 years 1 month ago

Education, Health, PRESS RELEASE, gis, grenada diabetes association, kathyann mitchell-victor, national diabetes quiz, world diabetes day

Health | NOW Grenada

Canada provides funding to Grenadian organisations

“These new projects will strengthen sexual and gender-based violence (SGBV) services in Grenada and increase public awareness of human rights through community outreach”

2 years 1 month ago

Community, Education, Health, PRESS RELEASE, Canada, canada fund for local initiatives, gis, grenada planned parenthood association, grenchap, lilian chatterjee

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Lupin gets USD 25 million from AbbVie for novel MALT1 inhibitor program to treat hematological cancers

New Delhi: Drug major Lupin on Thursday said it has received USD 25 million (around Rs 205 crore) from AbbVie Inc for meeting a key development milestone for a product to treat hematological cancers.

The company has achieved a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program that is partnered with AbbVie Inc towards treatment across a range of hematological cancers, the Mumbai-based drug maker said in a statement.

As part of the agreement, Lupin has received USD 25 million from AbbVie for initiation of Phase 1 clinical studies successfully, it added.

The drug maker had earlier received USD 30 million from AbbVie for achievement of other milestones in the programme.

Read Also: Lupin Unveils Rufinamide Oral Suspension For Seizure Disorder In US

"This achievement is further validation of our ability to successfully develop novel treatments for unmet needs. We look forward to continued successful development of this important treatment for patients with difficult-to-treat cancers," Lupin Managing Director Nilesh Gupta said in a statement.

Lupin and AbbVie inked the licensing, development, and commercialisation agreement in 2018 for a novel oncology drug to treat hematological cancers.

The company said its novel drug discovery and development (NDDD) team is focused on building a pipeline of highly differentiated and innovative new chemical entities in the oncology space.

Read Also: Lupin Receives Over Rs 205 Crore From AbbVie For Meeting Key Product Development Milestone

2 years 1 month ago

News,Industry,Pharma News,Latest Industry News

Pages